Keith Tan

2.8k total citations
49 papers, 1.6k citations indexed

About

Keith Tan is a scholar working on Pharmacology, Physiology and Surgery. According to data from OpenAlex, Keith Tan has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Physiology and 10 papers in Surgery. Recurrent topics in Keith Tan's work include Renal Transplantation Outcomes and Treatments (8 papers), Transplantation: Methods and Outcomes (7 papers) and Antifungal resistance and susceptibility (7 papers). Keith Tan is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Transplantation: Methods and Outcomes (7 papers) and Antifungal resistance and susceptibility (7 papers). Keith Tan collaborates with scholars based in United Kingdom, United States and Sweden. Keith Tan's co-authors include Nicky Best, Walter R. Gilks, Nolan Wood, Konrad E. Tomaszewski, Peter F. Troke, Andrew K. Trull, Gary Layton, Nicola Best, Satoshi Sobue and J. Wallwork and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Neurology.

In The Last Decade

Keith Tan

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Tan United Kingdom 21 338 327 321 218 186 49 1.6k
Bo Martin Bibby Denmark 33 163 0.5× 149 0.5× 428 1.3× 107 0.5× 396 2.1× 123 3.3k
Donald J. Schuirmann United States 13 70 0.2× 1.1k 3.3× 94 0.3× 189 0.9× 221 1.2× 21 2.6k
Dana C. Crawford United States 35 106 0.3× 187 0.6× 429 1.3× 154 0.7× 2.1k 11.1× 151 5.9k
Daijin Ko United States 23 274 0.8× 136 0.4× 152 0.5× 72 0.3× 878 4.7× 45 4.1k
Nengjun Yi United States 36 85 0.3× 233 0.7× 267 0.8× 52 0.2× 1.4k 7.6× 149 4.2k
Lisa Bastarache United States 20 84 0.2× 66 0.2× 231 0.7× 76 0.3× 967 5.2× 60 3.0k
Joseph E. Lucas United States 26 203 0.6× 134 0.4× 522 1.6× 125 0.6× 1.3k 6.9× 69 2.9k
Brooke L. Fridley United States 37 80 0.2× 89 0.3× 267 0.8× 98 0.4× 2.6k 14.1× 221 5.1k
Franck Picard France 24 30 0.1× 135 0.4× 145 0.5× 61 0.3× 1.1k 5.9× 79 2.6k
Niall Anderson United Kingdom 34 106 0.3× 106 0.3× 807 2.5× 188 0.9× 552 3.0× 84 3.5k

Countries citing papers authored by Keith Tan

Since Specialization
Citations

This map shows the geographic impact of Keith Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Tan more than expected).

Fields of papers citing papers by Keith Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Tan. The network helps show where Keith Tan may publish in the future.

Co-authorship network of co-authors of Keith Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Tan. A scholar is included among the top collaborators of Keith Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Tan. Keith Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Keith, et al.. (2025). AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer’s Disease clinical trial. Nature Communications. 16(1). 6244–6244. 4 indexed citations
2.
Wróbel, Lidia, Sandra Malmgren Hill, Marian Fernandez-Estévez, et al.. (2022). Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. Nature Communications. 13(1). 4146–4146. 23 indexed citations
3.
Gopalakrishnan, Vancheswaran, Richard N. Hanna, Eliseo Papa, et al.. (2022). StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit. Frontiers in Genetics. 13. 868015–868015. 9 indexed citations
4.
Hill, Sandra Malmgren, Lidia Wróbel, Avraham Ashkenazi, et al.. (2021). VCP/p97 regulates Beclin-1-dependent autophagy initiation. Nature Chemical Biology. 17(4). 448–455. 100 indexed citations
5.
Bogstedt, Anna, Maria Groves, Keith Tan, et al.. (2015). Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies. Journal of Alzheimer s Disease. 46(4). 1091–1101. 4 indexed citations
6.
Birger, Ruthie, Ricky Banarsee, David Bennett, et al.. (2011). Identification of patients with neuropathic pain using electronicprimary care records. Journal of Innovation in Health Informatics. 19(2). 83–90. 17 indexed citations
7.
Florian, Jeffry, S. Bramwell, Mark J. Field, et al.. (2010). Pharmacokinetic–Pharmacodynamic Analysis of the Static Allodynia Response to Pregabalin and Sildenafil in a Rat Model of Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 334(2). 599–608. 20 indexed citations
8.
Smith, Michael K., Ieuan Jones, Mark Morris, Andrew P. Grieve, & Keith Tan. (2006). Implementation of a Bayesian adaptive design in a proof of concept study. Pharmaceutical Statistics. 5(1). 39–50. 37 indexed citations
9.
Tan, Keith, et al.. (2006). Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities. The Journal of Clinical Pharmacology. 46(2). 235–243. 198 indexed citations
10.
Sobue, Satoshi, et al.. (2004). Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers. European Journal of Clinical Pharmacology. 60(4). 247–53. 10 indexed citations
11.
Sobue, Satoshi, Keith Tan, Gary Layton, Malcolm D. Eve, & J. B. Sanderson. (2004). Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers. British Journal of Clinical Pharmacology. 58(1). 20–25. 24 indexed citations
12.
Sobue, Satoshi, et al.. (2004). Pharmacokinetics and Safety of Fosfluconazole after Single Intravenous Bolus Injection in Healthy Male Japanese Volunteers. The Journal of Clinical Pharmacology. 44(3). 284–292. 13 indexed citations
13.
Wood, Nolan, Keith Tan, Richard Allan, Anitra Fielding, & D. J. Nichols. (2001). Effect of voriconazole on the pharmacokinetics of omeprazole. 41. 2. 2 indexed citations
14.
Best, Nicola, Keith Tan, Andrew K. Trull, et al.. (1996). PHARMACODYNAMICS OF CYCLOSPORINE IN HEART AND HEART-LUNG TRANSPLANT RECIPIENTS. Transplantation. 62(10). 1436–1441. 8 indexed citations
15.
Best, Nicola, Andrew K. Trull, Keith Tan, et al.. (1996). PHARMACODYNAMICS OF CYCLOSPORINE IN HEART AND HEART-LUNG TRANSPLANT RECIPIENTS. Transplantation. 62(10). 1429–1435. 7 indexed citations
16.
Herbison, Allan E., et al.. (1995). Increased Fos Expression in Preoptic Calcitonin Gene‐Related Peptide (CGRP) Neurones following Mating but not the Luteinizing Hormone Surge in Female Rats. Journal of Neuroendocrinology. 7(5). 377–385. 13 indexed citations
17.
Tan, Keith, et al.. (1995). Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis. European Journal of Clinical Pharmacology. 48-48(3-4). 285–9. 23 indexed citations
18.
Best, Nicola, Andrew K. Trull, Keith Tan, et al.. (1995). BLOOD CYCLOSPORINE CONCENTRATIONS AND CYTOMEGALOVIRUS INFECTION FOLLOWING HEART TRANSPLANTATION. Transplantation. 60(7). 689–694. 12 indexed citations
19.
Anyaoku, V., Diana Wood, Paul Williams, et al.. (1993). An enzyme-linked immunoadsorbent assay for human pituitary glycoprotein free α-subunit: evaluation and initial experience in patients with pituitary disease. Journal of Endocrinology. 136(3). 511–516. 3 indexed citations
20.
Tan, Keith, Andrew K. Trull, Rosalind L. Smyth, et al.. (1990). Altered Pharmacokinetics of Cyclosporin in Heart-Lung Transplant Recipients with Cystic Fibrosis. Therapeutic Drug Monitoring. 12(6). 520–524. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Martin Bibby Breakdown of academic impact, for papers by Donald J. Schuirmann Breakdown of academic impact, for papers by Dana C. Crawford Breakdown of academic impact, for papers by Daijin Ko Breakdown of academic impact, for papers by Nengjun Yi Breakdown of academic impact, for papers by Lisa Bastarache Breakdown of academic impact, for papers by Joseph E. Lucas Breakdown of academic impact, for papers by Brooke L. Fridley Breakdown of academic impact, for papers by Franck Picard Breakdown of academic impact, for papers by Niall Anderson
Rankless by CCL
2026